Wilber Romero-Fernandez

Wilber Romero-Fernandez

Auto-generated profile, based on publicly available information

Wilber Romero-Fernandez

Department of Neurology, Vanderbilt University Medical Center, Nashville, TN 37240, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 December 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
ESElena Solopova
Elena Solopova
WRWilber Romero-Fernandez
Wilber Romero-Fernandez
HHHannah Harmsen
Hannah Harmsen
LVLissa Ventura-Antunes
Lissa Ventura-Antunes
EWEmmeline Wang
Emmeline Wang
MSMatthew Schrag
Matthew Schrag
We report the case of a 79-year-old woman with Alzheimer’s disease who participated in a Phase III randomized controlled trial called CLARITY-AD testing the experimental drug lecanemab. She was randomized to the placebo group and subsequently enrolled in an open-label extension which guaranteed she received the active drug. After the third biweekly infusion, she suffered a seizure characterized by speech arrest and a generalized convulsion. Magnetic resonance imaging revealed she had multifocal swelling and a marked increase in the number of cerebral microhemorrhages. She was treated with an antiepileptic regimen and high-dose intravenous corticosteroids but continued to worsen and died after 5 days. Post-mortem MRI confirmed extensive microhemorrhages in the temporal, parietal and occipital lobes. The autopsy confirmed the presence of two copies of APOE4, a gene associated with a higher risk of Alzheimer’s disease, and neuropathological features of moderate severity Alzheimer’s disease and severe cerebral amyloid angiopathy with perivascular lymphocytic infiltrates, reactive macrophages and fibrinoid degeneration of vessel walls. There were deposits of β-amyloid in meningeal vessels and penetrating arterioles with numerous microaneurysms. We conclude that the patient likely died as a result of severe cerebral amyloid-related inflammation.

13 March 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
LVLissa Ventura-Antunes
Lissa Ventura-Antunes
ANAlex Nackenoff
Alex Nackenoff
WRWilber Romero-Fernandez
Wilber Romero-Fernandez
ABAllison M Bosworth
Allison M Bosworth
APAlex Prusky
Alex Prusky
MSMatthew Schrag
Matthew Schrag
Cerebral amyloid angiopathy (CAA) is a vasculopathy characterized by vascular β-amyloid (Aβ) deposition on cerebral blood vessels. CAA is closely linked to Alzheimer’s disease (AD) and intracerebral hemorrhage. CAA is associated with the loss of autoregulation in the brain, vascular rupture, and cognitive decline. To assess morphological and molecular changes associated with the degeneration of penetrating arterioles in CAA, we analyzed post-mortem human brain tissue from 26 patients with mild, moderate, and severe CAA end neurological controls. The tissue was optically cleared for three-dimensional light sheet microscopy, and morphological features were quantified using surface volume rendering. We stained Aβ, vascular smooth muscle (VSM), lysyl oxidase (LOX), and vascular markers to visualize the relationship between degenerative morphological features, including vascular dilation, dolichoectasia (variability in lumenal diameter) and tortuosity, and the volumes of VSM, Aβ, and LOX in arterioles. Atomic force microscopy (AFM) was used to assess arteriolar wall stiffness, and we identified a pattern of morphological features associated with degenerating arterioles in the cortex. The volume of VSM associated with the arteriole was reduced by around 80% in arterioles with severe CAA and around 60% in cases with mild/moderate CAA. This loss of VSM correlated with increased arteriolar diameter and variability of diameter, suggesting VSM loss contributes to arteriolar laxity. These vascular morphological features correlated strongly with Aβ deposits. At sites of microhemorrhage, Aβ was consistently present, although the morphology of the deposits changed from the typical organized ring shape to sharply contoured shards with marked dilation of the vessel. AFM showed that arteriolar walls with CAA were more than 400% stiffer than those without CAA. Finally, we characterized the association of vascular degeneration with LOX, finding strong associations with VSM loss and vascular degeneration. These results show an association between vascular Aβ deposition, microvascular degeneration, and increased vascular stiffness, likely due to the combined effects of replacement of VSM by β-amyloid, cross-linking of extracellular matrices (ECM) by LOX, and possibly fibrosis. This advanced microscopic imaging study clarifies the association between Aβ deposition and vascular fragility. Restoration of physiologic ECM properties in penetrating arteries may yield a novel therapeutic strategy for CAA.

1 September 2014 in Current Protein & Peptide Science
Verified
Journal Article
Open access
KCKathleen Van Craenenbroeck
Kathleen Van Craenenbroeck
Dasiel Oscar Borroto EscuelaDasiel Oscar Borroto Escuela
Dasiel Oscar Borroto Escuela
KSKamila Skieterska
Kamila Skieterska
JDJolien Duchou
Jolien Duchou
WRWilber Romero-Fernandez
Wilber Romero-Fernandez
KFKjell Fuxe
Kjell Fuxe
Dopamine receptors are G protein-coupled receptors critically involved in locomotion, reward, and cognitive processes. Export of dopamine receptors to the plasma membrane is thought to follow the default secretory pathway, whereby proteins travel from the endoplasmatic reticulum (ER), through the Golgi apparatus, to arrive at the cell surface. Several observations indicate that trafficking from the ER to the plasma membrane is tightly regulated, and that correct folding in the ER acts as a bottle neck to the maturation of the dopamine D4 receptors. The dopamine D4 receptor is an interesting receptor since it has a polymorphic region in its third intracellular loop, resulting in receptor isoforms of varying length and amino acid composition. Correct folding is enhanced by: (1) interaction with specific proteins, such as ER resident chaperones, (2) interaction with pharmacological chaperones, for example, ligands that are membrane permeable and can bind to the receptor in the ER, and (3) receptor dimerization; the assembly of multisubunit proteins into a quaternary structure is started in the ER before cell surface delivery, which helps in correct folding and subsequent expression. These interactions help the process of GPCR folding, but more importantly they ensure that only properly folded proteins proceed from the ER to the trans-Golgi network. In this review we will mainly focus on the role of receptor dimerization in dopamine D4 receptor maturation.

16 June 2023 in Alzheimer's & Dementia
Verified
Journal Article
Open access
WFWilber Romero Fernandez
Wilber Romero Fernandez
LALissa Ventura Antunes
Lissa Ventura Antunes
KKKetaki A. Katdare
Ketaki A. Katdare
KBKylie M. Balotin
Kylie M. Balotin
APAlex Prusky
Alex Prusky
MSMatthew Schrag
Matthew Schrag
Background: Proteinopathy is a common feature of multiple neurodegenerative diseases. Recent studies have demonstrated lysosomal dysfunction is closely linked to neurodegenerative proteinopathies. In the context of Alzheimer’s disease (AD), the lysosomal protein phospholipase D3 (PLD3) has been identified as a potential molecular player, but PLD3’s distinct role in lysosome function is not completely understood.Method: We used immunohistochemistry, western blot, and proximity ligation assays to determine PLD3’s localization, expression level, post‐translational modification and protein‐protein interaction profile. Experiments were performed using iPSC‐neuron cultures and human brain tissue obtained from patients with AD and neurological controls through the Vanderbilt Brain and Biospecimen Bank.Result: PLD3 is neuronal widely distributed throughout brain regions relevant to memory and cognition and PLD3 levels were significantly lower in AD brains compared to the controls. We discovered that PLD3 ubiquitination was significantly increased in AD brains relative to the controls, providing a possible explanation for the PLD3 reduction and localization into hallmark pathological structures of the AD brain. Furthermore, PLD3‐ubiquitin complexes were enriched in parenchymal β‐amyloid deposits and intraneuronal tau pathologies, both neuropil threads and neurofibrillary tangles.We provide the first experimental evidence for the physical interaction between PLD3 and Cathepsin D (CTD), both in human brain tissue and iPSC neurons. The interaction between PLD3/CTD was promoted by exposure of iPSC‐neurons to human Aβ seeds isolated from post‐mortem brain, suggesting this protein‐protein interaction is relevant to Aβ pathology. We found this heterodimer was dramatically reduced in AD brain, especially in dystrophic neurites. The loss of this interaction in dystrophic neurites is notable because even though PLD3 levels are reduced in the AD brain, both PLD3 and CTD are present in abundance around β‐amyloid plaques. The loss of PLD3/CTD interaction observed in AD brain is only partly explained by reduced expression of both proteins, so it is likely that an alteration in lysosome function is impacting this protein‐protein interaction.Conclusion: This study revealed an important role for both PLD3 ubiquitination and as an interaction partner for CTD within lysosomes. It will be interesting to further dissect the molecular mechanisms underlying the PLD3/CTD interaction.

18 July 2026 in Acta Neuropathologica Communications
Verified
Journal Article
Open access
PDF file
CMCody R. Marshall
Cody R. Marshall
FMFelipe A. Moser
Felipe A. Moser
CSClaire F. Scott
Claire F. Scott
LVLissa Ventura-Antunes
Lissa Ventura-Antunes
WRWilber Romero-Fernandez
Wilber Romero-Fernandez
JSJeffrey M. Spraggins
Jeffrey M. Spraggins
Cerebral amyloid angiopathy (CAA) commonly co-occurs with Alzheimer’s disease (AD), yet the molecular changes that accompany vascular $$\upbeta $$-am

16 February 2023 in Research Square
Verified
Preprint
Open access
PDF file
WRWilber Romero-Fernandez
Wilber Romero-Fernandez
CCCristian Carvajal-Tapia
Cristian Carvajal-Tapia
APAlex Prusky
Alex Prusky
KKKetaki Katdare
Ketaki Katdare
EWEmmeline Wang
Emmeline Wang
MSMatthew Schrag
Matthew Schrag
Examination of healthy and diseased human brain is essential to translational neuroscience. Protein-protein interactions play a pivotal role in physiological and pathological processes, but their detection is difficult, especially in aged and fixed human brain tissue. We used the proximity ligation assay (PLA) to broaden the range of molecular interactions assessable in-situ in human neuropathology. We adapted fluorescent in-situ PLA to detect ubiquitin-modified proteins in human brains with Alzheimer’s disease (AD), including approaches for the management of autofluorescence and quantification using a high-content image analysis system. We confirmed that hyperphosphorylated microtubule-associated protein tau (Serine202, Threonine205) aggregates were modified by ubiquitin and that phospho-tau-ubiquitin complexes were increased in hippocampal and frontal cortex regions in AD compared to non-AD brains. Overall, we refined PLA for use in human neuropathology, which has revealed a profound change in the distribution of ubiquitin in AD brain and its association with characteristic tau pathologies.